J E Leestma1, J F Annegers, M J Brodie
1Chicago Institute of Neurosurgery and Neuroresearch, Illinois, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
The rate of sudden unexplained death in epilepsy (SUDEP) among patients in lamotrigine clinical trials was 3.5 per 1,000 patient-years. This SUDEP rate is comparable to expected rates in high-risk epilepsy populations.
Area of Science:
Background: